Nicola Mikulcik Ohrner
Corporate Officer/Principal at FORMYCON AG
Nicola Mikulcik Ohrner active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FORMYCON AG | Corporate Officer/Principal | 01/06/2022 | - |
bioeq GmbH
 bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Chief Executive Officer | - | - |
Bioeq AG
 Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Director/Board Member | - | - |
Career history of Nicola Mikulcik Ohrner
Statistics
International
| Germany | 3 |
| Switzerland | 2 |
Operational
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Private companies | 2 |
|---|---|
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |
